Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

FR Toulouse Dray C

From Bioblast


                



FR Toulouse Dray C

Oroboros O2k-Network

O2k-Network
O2k-Network Lab INSERM U 1048, équipe n°3

Institut des Maladies Métaboliques et Cardiovasculaires

Address 1 Avenue du Professeur Jean Poulhes, 31400
City Toulouse
State/Prov
Country France
Weblink
Contact Dray Cedric
Team
Team previous
Status O2k 2015-
Oroboros Events
Topics


O2k-Publications

 PublishedReference
Valet 2015 US Patent2015Valet P, Dray C, Knauf C, Kunduzova O, Castan-Laurell I (2015) Pharmaceutical composition for use in the treatment of dysfunction associated with aging. US Patent US20150290286 A1.
Attane 2012 Diabetes2012Attané C, Foussal C, Le Gonidec S, Benani A, Daviaud D, Wanecq E, Guzmán-Ruiz R, Dray C, Bezaire V, Rancoule C, Kuba K, Ruiz-Gayo M, Levade T, Penninger J, Burcelin R, Pénicaud L, Valet P, Castan-Laurell I (2012) Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes 61:310-20.
Knauf 2008 Endocrinology2008Knauf C, Cani PD, Ait-Belgnaoui A, Benani A, Dray C, Cabou C, Colom A, Uldry M, Rastrelli S, Sabatier E, Godet N, Waget A, Pénicaud L, Valet P, Burcelin R (2008) Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure. Endocrinology 149:4768-77.

O2k-Abstracts

update please